Exploiting the Human Peptidome for Novel Antimicrobial and Anticancer Agents

The human peptidome (i.e. the entirety of peptides in the body) comprises millions of diverse agents including key regulators and effectors of innate and adaptive immunity. To date, only a small fraction of endogenous peptides has been functionally characterized and the peptidome represents an almost unlimited resource for the discovery of novel effector molecules. The main goal of CRC 1279 is thus to use the human peptidome to discover endogenous peptides playing key roles in the control of human pathogens and cancers, and to apply state of the art technologies to optimize them for translational in vivo applications.

alternative Erklärung

Whats in the news

SARS-CoV-2 detected in breast milk

The CRC1279 congratulates Prof. Dr. Jan Münch and his team at the Institute of Molecular Virology Ulm on the first publication of the detection of SARS-CoV-2 in human breast milk 1.

by Kristina Hopfensperger | June 19, 2020

Fighting SARS-CoV-2 – Establishing the basis for future therapeutic strategies
Prof. Dr. Frank Kirchhoff and Jun.-Prof. Dr. Daniel Sauter from the Institute of Molecular Virology receive over 900 000 Euro funding from the Federal Ministry of Education and Research (BMBF) for two new SARS-CoV-2 research projects. Congratulations!

by Kristina Hopfensperger | June 12, 2020

CRC 1279 at the 5th German Pharm-Tox Summit

Congratulations to Maximilian Fellermann who received the young researchers award from the Thieme journal ‘Research’ for the ‘Best Short Presentation 2020 in the subject of Toxicology’.

by Kristina Hopfensperger | March 31, 2020

Fight nCoV – Joint forces for a therapy or vaccine against SARS-CoV-2

The professors Jan Münch from the University of Ulm and Thomas Schrader from the University of Duisburg-Essen collaborate with other European scientists within the new EU project ‘Fight-nCoV’. The scientific aim of the project is to test drug candidates against the new coronavirus. Promising candidates are, amongst others, molecular tweezers developed by Profs. Münch and Schrader.

March 26, 2020 | 🔗 schwaebische.de

The essentials of science communication
The relevance of science communication has been steadily increasing during the last years. The CRC1279 invited Dr. Tobias Maier from the National Institute for Science Communication in Karlsruhe to host a workshop in Ulm.

by Kristina Hopfensperger | March 10, 2020

Introducing the new President of the German Society of Experimental and Clinical Pharmacology and Toxicology: Prof. Dr. Holger Barth
The German Society of Experimental and Clinical Pharmacology and Toxicology (DGPT) nominated CRC1279 member Prof. Dr. Holger Barth to be their president for 2020. Prof. Dr. Barth took over the responsibilities from the outgoing president Prof. Dr. Wieland.

by Kristina Hopfensperger | February 10, 2020

Ein Mantel, der Viren gefährlicher macht

Our former colleque Dr. Annika Röcker wrote many articles for the CRC1279 homepage, now she is writing for the German Journal "Spektrum der Wissenschaft" ... in this case about our Swedish collaborators.

by Dr. Annika Röcker | January 10, 2020 | 🔗 Spektrum.de

International CRC1279 symposium at Lake Federsee

At the 22nd and 23rd of October over 60 CRC1279 members and several international experts joined the international CRC1279 symposium in Bad Buchau next to the beautiful lake Federsee.

by Kristina Hopfensperger | November 25, 2019

The proud winners of the Creative Young Investigators Award

The CRC1279 congratulates the Creative Young Investigators Award Winners: Katharina Ernst, Mirja Harms, Dr. Yasser Ruiz-Blanco, Dr. Konstantin Sparrer and Dr. Stephanie Wehrstedt.

by Kristina Hopfensperger | October 15, 2019

Grand visit - Grant accepted

On July 22nd, CRC 1279 welcomed Dr. Beatrice Hahn, a Professor of Medicine at the Perelman School of Medicine in Philadelphia and a leading AIDS researcher worldwide.

by Kristina Hopfensperger | August 19, 2019

Time to say goodbye… and hello Kristina!

Annika Röcker, so far responsible for Public Relations and Event reports of the CRC homepage, will leave us by the end of March 2019. Luckily, Kristina Hopfensperger will take over.

by Dr. Annika Röcker, Kristina Hopfensperger and Prof. Dr. Frank Kirchhoff


CRC secretariat:
Kristina Wohllaib
Tel: 0731 500 65152
mail: kristina.wohllaib@uni-ulm.de

Kirchhoff, Frank, Prof. Dr.
Institute of Molecular Virology
Ulm University Medical Center
Meyerhofstr. 1
89081 Ulm
Tel.: 0731 50065150
mail: frank.kirchhoff@uni-ulm.de

    CRC 1279 Upcoming Events

  • For more information and previous CRC1279 Monday Seminars klick here

Building the CRC1279 Webpage

alternative Erklärung

Public Relations and Content

Kristina Hopfensperger: kristina.hopfensperger@uni-ulm.de
PhD student at the institute of Molecular Virology Ulm

alternative Erklärung

Web Design and Content

Dr. Dré van der Merwe:
Lab Manager at the institute of Molecular Virology Ulm

alternative Erklärung

Web Design

Fabian Zech:
PhD student at the institute of Molecular Virology Ulm